Allurion Technologies
Watchlist
Allurion announces study of its gastric balloon in connection with GLP-1 products! Volatile stock rises 100% in pre-market!
Reading Time: 3 minutes
Allurion Technologies (ALUR) published a press release on Thursday, January 23, 2025, announcing its plans to optimize muscle mass during GLP-1 therapy in combination with the Allurion program. The stock price surged over 100% in after-hours trading to more than $7. Allurion Technologies takes on the fight against obesity Allurion is committed to combating obesity. The Allurion program is a weight loss platform that features the Allurion gastric balloon, the world's first and only swallowable gastric balloon for weight loss that can be deployed...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
